Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2020 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2020 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling

  • Authors:
    • Zhipeng Hu
    • Bowen Li
    • Zhiwei Wang
    • Xiaoping Hu
    • Min Zhang
    • Ruoshi Chen
    • Qi Wu
    • Fangyuan Jia
  • View Affiliations / Copyright

    Affiliations: Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
    Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].
  • Pages: 387-397
    |
    Published online on: April 22, 2020
       https://doi.org/10.3892/mmr.2020.11088
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The sympathetic system is involved in the arterial diseases, but its mechanism remains poorly understood. The present study aimed to explore the impact of the sympathetic neurotransmitter norepinephrine (NE) on transforming growth factor (TGF) β signaling and the role of NE in aortic remodeling. Guanethidine was used to induce a regional chemical sympathetic denervation (CSD) in angiotensin II (AngII) and β‑aminopropionitrile (BAPN)‑induced aortic aneurysm models. The diameter of the aorta was measured, and elastic fiber staining was performed. TGFβ type I receptor kinase (ALK5) expression in rat aortic NE‑treated vascular smooth muscle cells (VSMCs) was detected by reverse transcription‑quantitative PCR and western blotting. The effects of NE and ALK5 overexpression on migration, proliferation, apoptosis and TGFβ signaling were also evaluated. Furthermore, adrenergic receptor blockers were used to determine which receptor was involved in the modulation on TGFβ signaling by NE. The results of the present study demonstrated that CSD protected rats from AngII+BAPN‑induced aortic remodeling and aneurysm formation. Compared with the control group, NE inhibited VSMC proliferation and migration, but promoted apoptosis by suppressing ALK5 expression, reversing the effects of TGFβ signaling through the suppression of the SMAD‑dependent canonical pathway and promotion of the non‑canonical pathway. These effects were prevented by ALK5 overexpression. The inhibition of α‑ or β‑adrenergic receptors alleviated the NE‑mediated suppression of ALK5 expression. In conclusion, regional CSD protected rats from aortic aneurysm. NE inhibited SMAD2/3‑dependent TGFβ signaling by suppressing ALK5 expression, which may serve an important role in VSMC biological functions. Both α‑ and β‑adrenergic receptors were involved in the regulation of ALK5 expression by NE. Abnormal sympathetic innervation of the aorta may be used as a therapeutic target in aortic diseases.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Akutsu K, Kawamoto M, Sato N, Yamamoto T, Tamura K, Mizuno K and Tanaka K: Acute aortic dissection associated with cystic medial necrosis of unknown etiology. J Nippon Med Sch. 79:159–162. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Fraga-Silva RA and Trachet B: Editorial: Novel insights on aortic aneurysm. Curr Pharm Des. 21:3993–3995. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Zhipeng H, Zhiwei W, Lilei Y, Hao Z, Hongbing W, Zongli R, Hao C and Xiaoping H: Sympathetic hyperactivity and aortic sympathetic nerve sprouting in patients with thoracic aortic dissection. Ann Vasc Surg. 28:1243–1248. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Hu R, Wang Z, Ren Z and Liu M: Autonomic remodeling may be responsible for decreased incidence of aortic dissection in STZ-induced diabetic rats via down-regulation of matrix metalloprotease 2. BMC Cardiovasc Disord. 16:2002016. View Article : Google Scholar : PubMed/NCBI

5 

Hu Z, Wang Z, Wu H, Yang Z, Jiang W, Li L and Hu X: Ang II enhances noradrenaline release from sympathetic nerve endings thus contributing to the up-regulation of metalloprotease-2 in aortic dissection patients' aorta wall. PLoS One. 8:e769222013. View Article : Google Scholar : PubMed/NCBI

6 

Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, et al: Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 355:788–798. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Lindsay ME and Dietz HC: Lessons on the pathogenesis of aneurysm from heritable conditions. Nature. 473:308–316. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Yang YF, Wu CC, Chen WP and Su MJ: Transforming growth factor-beta type I receptor/ALK5 contributes to doxazosin-induced apoptosis in H9C2 cells. Naunyn Schmiedebergs Arch Pharmacol. 380:561–567. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, et al: Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Devel Ther. 9:4479–4499. 2015.PubMed/NCBI

10 

Santini V, Valcárcel D, Platzbecker U, Komrokji RS, Cleverly AL, Lahn MM, Janssen J, Zhao Y, Chiang A, Giagounidis A, et al: Phase II study of the ALK5 inhibitor galunisertib in very low-, low-, and intermediate-risk myelodysplastic syndromes. Clin Cancer Res. 25:6976–6985. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Kawai T, Takayanagi T, Forrester SJ, Preston KJ, Obama T, Tsuji T, Kobayashi T, Boyer MJ, Cooper HA, Kwok HF, et al: Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) is required for angiotensin II/β-aminopropionitrile-induced abdominal aortic aneurysm. Hypertension. 70:959–963. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, Weiss SJ, Itoh H, Hori S, Aikawa N and Okada Y: Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation. 126:3070–3080. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Nagashima H, Uto K, Sakomura Y, Aoka Y, Sakuta A, Aomi S, Hagiwara N, Kawana M and Kasanuki H: An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg. 36:818–823. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Hong J, Hu Z, Wu Q, Tang C, Hu J, Chen R, Li B and Wang Z: The deregulation of STIM1 and store operative calcium entry impaired aortic smooth muscle cells contractility in aortic medial degeneration. Biosci Rep. 39:BSR201815042019. View Article : Google Scholar : PubMed/NCBI

15 

Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Mallem Y, Holopherne D, Reculeau O, Le Coz O, Desfontis JC and Gogny M: Beta-adrenoceptor-mediated vascular relaxation in spontaneously hypertensive rats. Auton Neurosci. 118:61–67. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Shirai K, Song M, Suzuki J, Kurosu T, Oyama T, Nagayama D, Miyashita Y, Yamamura S and Takahashi M: Contradictory effects of β1- and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)-CAVI independent of blood pressure. J Atheroscler Thromb. 18:49–55. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Thomas P and Dasgupta I: The role of the kidney and the sympathetic nervous system in hypertension. Pediatr Nephrol. 30:549–560. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Parati G and Esler M: The human sympathetic nervous system: Its relevance in hypertension and heart failure. Eur Heart J. 33:1058–1066. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Eichmann A and Brunet I: Arterial innervation in development and disease. Sci Transl Med. 6:252ps2592014. View Article : Google Scholar

21 

Woolgar JR and Scott TM: The relationship between innervation and arterial structure in late prenatal and early postnatal development of the rat jejunal artery. J Anat. 167:57–70. 1989.PubMed/NCBI

22 

Hernigou J, Dakhil B, Belmont L, Couffinhal JC and Bagan P: Sleep apnea syndrome and abdominal aortic aneurysm: Study of the prevalence of sleep apnea syndrome in patients with aneurysm and research of association. Clinical study on 52 patients. J Med Vasc. 42:162–169. 2017.(In French). PubMed/NCBI

23 

Sampol G, Romero O, Salas A, Tovar JL, Lloberes P, Sagalés T and Evangelista A: Obstructive sleep apnea and thoracic aorta dissection. Am J Respir Crit Care Med. 168:1528–1531. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Yanagi H, Imoto K, Suzuki S, Uchida K, Masuda M and Miyashita A: Acute aortic dissection associated with sleep apnea syndrome. Ann Thorac Cardiovasc Surg. 19:456–460. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Bradley TD and Floras JS: Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 373:82–93. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Schiza SE, Mermigkis C and Bouloukaki I: The effect of obstructive sleep apnea syndrome and snoring severity to intima-media thickening of carotid artery. Sleep Breath. 19:25–27. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Ruijtenbeek K, le Noble FA, Janssen GM, Kessels CG, Fazzi GE, Blanco CE and De Mey JG: Chronic hypoxia stimulates periarterial sympathetic nerve development in chicken embryo. Circulation. 102:2892–2897. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Angouras DC, Dosios TJ, Dimitriou CA, Chamogeorgakis TP, Rokkas CK, Manos TA and Sokolis DP: Surgical thoracic sympathectomy induces structural and biomechanical remodeling of the thoracic aorta in a porcine model. J Surg Res. 172:68–76. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM and Powell JT; UK Small Aneurysm Trial Participants, : Abdominal aortic aneurysm expansion: Risk factors and time intervals for surveillance. Circulation. 110:16–21. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Ma J, Zhang L, He G, Tan X, Jin X and Li C: Transcutaneous auricular vagus nerve stimulation regulates expression of growth differentiation factor 11 and activin-like kinase 5 in cerebral ischemia/reperfusion rats. J Neurol Sci. 369:27–35. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Aspalter IM, Gordon E, Dubrac A, Ragab A, Narloch J, Vizán P, Geudens I, Collins RT, Franco CA, Abrahams CL, et al: Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. Nat Commun. 6:72642015. View Article : Google Scholar : PubMed/NCBI

32 

Thomas M, Docx C, Holmes AM, Beach S, Duggan N, England K, Leblanc C, Lebret C, Schindler F, Raza F, et al: Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline. Am J Pathol. 174:380–389. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, et al: Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 332:358–361. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI

35 

Schmit BM, Yang P, Fu C, DeSart K, Berceli SA and Jiang Z: Hypertension overrides the protective effect of female hormones on the development of aortic aneurysm secondary to Alk5 deficiency via ERK activation. Am J Physiol Heart Circ Physiol. 308:H115–H125. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Carta L, Smaldone S, Zilberberg L, Loch D, Dietz HC, Rifkin DB and Ramirez F: p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem. 284:5630–5636. 2009. View Article : Google Scholar : PubMed/NCBI

37 

Fabiani ME, Sourial M, Thomas WG, Johnston CI, Johnston CI and Frauman AG: Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: Implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol. 171:97–108. 2001. View Article : Google Scholar : PubMed/NCBI

38 

Li JS, Li HY, Wang L, Zhang L and Jing ZP: Comparison of β-aminopropionitrile-induced aortic dissection model in rats by different administration and dosage. Vascular. 21:287–292. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu Z, Li B, Wang Z, Hu X, Zhang M, Chen R, Wu Q and Jia F: The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling. Mol Med Rep 22: 387-397, 2020.
APA
Hu, Z., Li, B., Wang, Z., Hu, X., Zhang, M., Chen, R. ... Jia, F. (2020). The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling. Molecular Medicine Reports, 22, 387-397. https://doi.org/10.3892/mmr.2020.11088
MLA
Hu, Z., Li, B., Wang, Z., Hu, X., Zhang, M., Chen, R., Wu, Q., Jia, F."The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling". Molecular Medicine Reports 22.1 (2020): 387-397.
Chicago
Hu, Z., Li, B., Wang, Z., Hu, X., Zhang, M., Chen, R., Wu, Q., Jia, F."The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling". Molecular Medicine Reports 22, no. 1 (2020): 387-397. https://doi.org/10.3892/mmr.2020.11088
Copy and paste a formatted citation
x
Spandidos Publications style
Hu Z, Li B, Wang Z, Hu X, Zhang M, Chen R, Wu Q and Jia F: The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling. Mol Med Rep 22: 387-397, 2020.
APA
Hu, Z., Li, B., Wang, Z., Hu, X., Zhang, M., Chen, R. ... Jia, F. (2020). The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling. Molecular Medicine Reports, 22, 387-397. https://doi.org/10.3892/mmr.2020.11088
MLA
Hu, Z., Li, B., Wang, Z., Hu, X., Zhang, M., Chen, R., Wu, Q., Jia, F."The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling". Molecular Medicine Reports 22.1 (2020): 387-397.
Chicago
Hu, Z., Li, B., Wang, Z., Hu, X., Zhang, M., Chen, R., Wu, Q., Jia, F."The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFβ by suppressing the expression of the TGFβ receptor ALK5 in aorta remodeling". Molecular Medicine Reports 22, no. 1 (2020): 387-397. https://doi.org/10.3892/mmr.2020.11088
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team